Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 314

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection

Open access
Nucci, Marcio, Anaissie, Elias J., Queiroz‐Telles, Flavio, Martins, Carlos A., Trabasso, Plínio, Solza, Cristiana, Mangini, Claudia, Simões, Belinda P., Colombo, Arnaldo L., Vaz, Jorge, Levy, Carlos E., Costa, Silvia, Moreira, Vaneusa A., Oliveira, José Salvador, Paraguay, Nestor, Duboc, Gisele, Voltarelli, Julio C., Maiolino, Angelo, Pasquini, Ricardo, Souza, Cármino A. · 2003 · Cancer

Abstract

BACKGROUND: Invasive infection by Fusarium sp. is associated with high mortality in patients with hematologic cancer. Yet to the authors' knowledge, little is known regarding predictors of adverse outcome. METHODS: The authors conducted a retrospective review of the records of patients with hematologic carcinoma and invasive fusariosis who were treated at one institution in the U.S. and at 11 centers in Brazil. RESULTS: The records of 84 patients were evaluated. Neutropenia was present in 83% and 33 patients had undergone stem cell transplantation. Only 18 patients (21%) were alive 90 days after the diagnosis of fusariosis. Multivariate predictors of poor outcome were persistent neutropenia (hazard ratio [HR] of 5.43; 95% confidence interval [95% CI], 2.64–11.11) and use of corticosteroids (HR of 2.18; 95% CI, 1.98–3.96). The actuarial survival rate of patients without any of these factors was 67% compared with 30% for patients who recovered from neutropenia but were receiving corticosteroids and 4% for patients with persistent neutropenia only. None of the patients with both risk factors survived (P < 0.0001). CONCLUSIONS: Measures to reduce the duration of neutropenia, as well as the judicious use of corticosteroids, may reduce the high mortality rate of fusariosis in patients with hematologic cancer. Cancer 2003;98:315–9. © 2003 American Cancer Society. DOI 10.1002/cncr.11510

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.11510

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 314

Metadata

Authors
Nucci, M., Anaissie, E. J., Queiroz‐Telles, F., Martins, C. A., Trabasso, P., Solza, C., Mangini, C., Simões, B. P., Colombo, A. L., Vaz, J., Levy, C. E., Costa, S., Moreira, V. A., Oliveira, J. S., Paraguay, N., Duboc, G., Voltarelli, J. C., Maiolino, A., Pasquini, R., & Souza, C. A.
Venue
Cancer
Publisher
Wiley
Published
2003-07-02
Volume
98
Issue
2
Pages
315-319
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2166960549
Cited by
314
References
17
FWCI
5.10
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. https://app.cochat.ai/papers/10.1002/cncr.11510
The paper
Nucci, M., Anaissie, E. J., Queiroz‐Telles, F., Martins, C. A., Trabasso, P., Solza, C., Mangini, C., Simões, B. P., Colombo, A. L., Vaz, J., Levy, C. E., Costa, S., Moreira, V. A., Oliveira, J. S., Paraguay, N., Duboc, G., Voltarelli, J. C., Maiolino, A., Pasquini, R., & Souza, C. A. (2003). Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. https://doi.org/10.1002/cncr.11510

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.